02 June 2024 : Database Analysis
ANXA5: A Key Regulator of Immune Cell Infiltration in Hepatocellular Carcinoma
Weichen Wang1A*, Dongquan Liu1B, Jiaming Yao1C, Zhongxu Yuan1E, Liang Yan1F, Baoqiang Cao1AGDOI: 10.12659/MSM.943523
Med Sci Monit 2024; 30:e943523
Figure 6 Relationship between risk model and immune infiltration(A) TIMER, CIBERSORT, CIBERSORT-ABS, QUANTISEQ, MCPCOUNTER, XCELL, and EPIC methods to evaluate the relative proportions of infiltrating immune cells. (B) Differences in immune function between high-risk and low-risk samples. (C) Differences in expression levels of immune checkpoints between high-risk and low-risk samples. (* P<0.05, ** P<0.01, *** P<0.001, ns – no significance)






